MILESAX finalist project during the ceremony “LE ECCELLENZE DELL’INFORMAZIONE SCIENTIFICA E LA CENTRALITA’ DEL PAZIENTE”, organized by Merqurio Holding, under the auspices of FNOMCeO and the Ministry of Health.
The scientific information represents the right tool to promote projects that have the chance to improve patients’ life quality. For this reason, the prize wanted to enhance projects with real benefits for people’s health and a progressfor the centrality adfirmation of the patient, entrusting the excellence choices to users of informative messages: doctors, responsable for patients’ cure. The identification of the excellences occurred through a selection process started from the sending of 250.000 surveys to doctors, who had to identified ethical and excellent projects, with the feature of innovation and oriented to an improvement of their patients’ life quality.
From a process that envisaged different valutation steps, there are now 39 projects, divided in 8 categories (including nutraceutics), subjected to a board’s evaluation, including MILESAX, which received the certificate of finalist project. Our project, mentioned with other 5 companies’ projects in the nutraceutical field, such as Mylan, Sigma Tau, Italfarmaco, Doc Generici and Camo, obteined the second place. A great result.
We are proud of this nomination, and it happened thanks to the daily work of the scientific information, done with ethical criteria, professionalism and excellence